Treatment of patients with advanced or metastatic bladder cancer
03/2018
MUDr. Jana Katolická, Ph.D.
Onkologicko-chirurgické oddělení FN u svaté Anny, Brno
SUMMARY
The most particular histological type of bladder cancer is urothelial carcinoma. The chemotherapeutic schedules for metastatic disease are based on derivatives of platinum. The imunotherapy is novel therapeutic possibility for patients with local advanced and metastatic disease.
KEY WORDS
metastatic urothelial bladder cancer, chemotherapy, imunotherapy
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...